Effects of CYP3A4*22 and CYP3A5 on clinical outcome in patients treated with ticagrelor for ST-segment elevation myocardial infarction: POPular Genetics sub-study.
Frontiers In Pharmacology
Azzahhafi, Jaouad J; Bergmeijer, Thomas O TO; van den Broek, Wout W A WWA; Chan Pin Yin, Dean R P P DRPP; Rayhi, Senna S; Peper, Joyce J; Bor, Willem L WL; Claassens, Daniel M F DMF; van Schaik, Ron H N RHN; Ten Berg, Jurriën M JM
Time-dependent inhibition of CYP3A4-mediated midazolam metabolism by macrolide antibiotics in CYP3A4 genetic variants: Comparison with testosterone metabolism.
International Journal Of Clinical Pharmacology And Therapeutics
Akiyoshi, Takeshi T; Naitou, Rina R; Imaoka, Ayuko A; Miyazaki, Mitsue M; Guengerich, F Peter FP; Nakamura, Katsunori K; Yamamoto, Koujiro K; Ohtani, Hisakazu H
Biomarkers for Antiplatelet Therapies in Acute Ischemic Stroke: A Clinical Review.
Frontiers In Neurology
Alhazzani, Adel A; Venkatachalapathy, Poongothai P; Padhilahouse, Sruthi S; Sellappan, Mohan M; Munisamy, Murali M; Sekaran, Mangaiyarkarasi M; Kumar, Amit A
Characterization of CYP3A pharmacogenetic variation in American Indian and Alaska Native communities, targeting CYP3A4*1G allele function.
Clinical And Translational Science
Fohner, Alison E AE; Dalton, Rachel R; Skagen, Kasse K; Jackson, Konner K; Claw, Katrina G KG; Hopkins, Scarlett E SE; Robinson, Renee R; Khan, Burhan A BA; Prasad, Bhagwat B; Schuetz, Erin G EG; Nickerson, Deborah A DA; Thornton, Timothy A TA; Dillard, Denise A DA; Boyer, Bert B BB; Thummel, Kenneth E KE; Woodahl, Erica L EL
Publication Date: 2021-07
Variant appearance in text: CYP3A4: G56D; rs56324128
Population Pharmacokinetic and Pharmacogenetic Analysis of Mitotane in Patients with Adrenocortical Carcinoma: Towards Individualized Dosing.
Clinical Pharmacokinetics
Yin, Anyue A; Ettaieb, Madeleine H T MHT; Swen, Jesse J JJ; van Deun, Liselotte L; Kerkhofs, Thomas M A TMA; van der Straaten, Robert J H M RJHM; Corssmit, Eleonora P M EPM; Gelderblom, Hans H; Kerstens, Michiel N MN; Feelders, Richard A RA; Eekhoff, Marelise M; Timmers, Henri J L M HJLM; D'Avolio, Antonio A; Cusato, Jessica J; Guchelaar, Henk-Jan HJ; Haak, Harm R HR; Moes, Dirk Jan A R DJAR
Publication Date: 2021-01
Variant appearance in text: CYP3A4: G56D; rs56324128
Characterization of ADME gene variation in 21 populations by exome sequencing.
Pharmacogenetics And Genomics
Hovelson, Daniel H DH; Xue, Zhengyu Z; Zawistowski, Matthew M; Ehm, Margaret G MG; Harris, Elizabeth C EC; Stocker, Sophie L SL; Gross, Annette S AS; Jang, In-Jin IJ; Ieiri, Ichiro I; Lee, Jong-Eun JE; Cardon, Lon R LR; Chissoe, Stephanie L SL; Abecasis, Gonçalo G; Nelson, Matthew R MR
Publication Date: 2017-03
Variant appearance in text: CYP3A4: G56D; rs56324128
The Affymetrix DMET Plus platform reveals unique distribution of ADME-related variants in ethnic Arabs.
Disease Markers
Wakil, Salma M SM; Nguyen, Cao C; Muiya, Nzioka P NP; Andres, Editha E; Lykowska-Tarnowska, Agnieszka A; Baz, Batoul B; Tahir, Asma I AI; Meyer, Brian F BF; Morahan, Grant G; Dzimiri, Nduna N
Integrated analysis of germline and somatic variants in ovarian cancer.
Nature Communications
Kanchi, Krishna L KL; Johnson, Kimberly J KJ; Lu, Charles C; McLellan, Michael D MD; Leiserson, Mark D M MD; Wendl, Michael C MC; Zhang, Qunyuan Q; Koboldt, Daniel C DC; Xie, Mingchao M; Kandoth, Cyriac C; McMichael, Joshua F JF; Wyczalkowski, Matthew A MA; Larson, David E DE; Schmidt, Heather K HK; Miller, Christopher A CA; Fulton, Robert S RS; Spellman, Paul T PT; Mardis, Elaine R ER; Druley, Todd E TE; Graubert, Timothy A TA; Goodfellow, Paul J PJ; Raphael, Benjamin J BJ; Wilson, Richard K RK; Ding, Li L
Reduced methylprednisolone clearance causing prolonged pharmacodynamics in a healthy subject was not associated with CYP3A5*3 allele or a change in diet composition.
Journal Of Clinical Pharmacology
Lee, Su-Jun SJ; Jusko, William J WJ; Salaita, Christine G CG; Calis, Karim A KA; Jann, Michael W MW; Spratlin, Vicky E VE; Goldstein, Joyce A JA; Hon, Yuen Yi YY